NCT06509230 Prediction of Significant Liver Fibrosis
| NCT ID | NCT06509230 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huang Haijun |
| Condition | Liver Fibrosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2024-07-20 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2024-07-20 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The deep learning method based on convolutional neural network (CNN) was used to extract the relevant features of liver fibrosis classification from the multi-modal information of digital pathological sections, clinical parameters and biomarkers of a large number of existing cases of liver puncture, and the U-Net architecture of CNN was used to segment and extract the features of clinical medical images.
Eligibility Criteria
Inclusion Criteria: 1. Age of 18-60 years old 2. The diagnosis of chronic hepatitis B is in line with the diagnostic criteria of China's 2019 Chronic Hepatitis B Prevention and Treatment Guidelines, and the diagnosis of non-alcoholic fatty liver is in line with the Asian Pacific Hepatology Association guidelines 3. Imaging showed no liver cancer Exclusion Criteria: 1. There are contraindications for liver biopsy 2. Liver pathology did not meet the criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06509230 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Liver Fibrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06509230 currently recruiting?
Yes, NCT06509230 is actively recruiting participants. Contact the research team at huanghaijun0826@163.com for enrollment information.
Where is the NCT06509230 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06509230 clinical trial?
NCT06509230 is sponsored by Huang Haijun. The trial plans to enroll 700 participants.